These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3296206)

  • 1. Intensive postremission therapy in adults with acute nonlymphocytic leukemia using various dose schedules of ara-C: a progress report from the CALGB. Cancer and Leukemia Group B.
    Mayer RJ; Schiffer CA; Peterson BA; Budman DR; Silver RT; Rai KR; Cornwell GG; Ellison RR; Maguire M; Berg DT
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):25-31. PubMed ID: 3296206
    [No Abstract]   [Full Text] [Related]  

  • 2. Intensive post-remission therapy with Ara-C in adults with acute myeloid leukemia: initial results of a CALGB phase III trial. The Cancer and Leukemia Group B.
    Mayer RJ; Davis RB; Schiffer CA; Berg DT; Sarno E; Frei E
    Leukemia; 1992; 6 Suppl 2():66-7. PubMed ID: 1578945
    [No Abstract]   [Full Text] [Related]  

  • 3. High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update.
    Wolff SN; Herzig RH; Phillips GL; Lazarus HM; Greer JP; Stein RS; Ray WA; Herzig GP
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):12-7. PubMed ID: 3589687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemia.
    Cassileth PA; Harrington DP; Hines JD; Oken MM; Mazza JJ; McGlave P; Bennett JM; O'Connell MJ
    J Clin Oncol; 1988 Apr; 6(4):583-7. PubMed ID: 3282032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive postremission therapy in adults with acute nonlymphocytic leukemia with ara-C by continuous infusion or bolus administration: preliminary results of a CALGB phase I study.
    Mayer RJ; Schiffer CA; Peterson BA; Silver RT; Cornwell GG; McIntyre OR; Rai KR; Budman DR; Ellison RR; Maguire M
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):84-90. PubMed ID: 4012343
    [No Abstract]   [Full Text] [Related]  

  • 6. Sequential studies of daunorubicin and adriamycin in acute nonlymphocytic leukemia.
    Wiernik PH
    Cancer Treat Rep; 1981; 65 Suppl 4():67-71. PubMed ID: 7049382
    [No Abstract]   [Full Text] [Related]  

  • 7. Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.
    Löwenberg B; Suciu S; Archimbaud E; Haak H; Stryckmans P; de Cataldo R; Dekker AW; Berneman ZN; Thyss A; van der Lelie J; Sonneveld P; Visani G; Fillet G; Hayat M; Hagemeijer A; Solbu G; Zittoun R
    J Clin Oncol; 1998 Mar; 16(3):872-81. PubMed ID: 9508168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Individualized chemotherapy of adult acute nonlymphocytic leukemia].
    Uzuka Y; Saito Y
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1473-80. PubMed ID: 2389943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remission-induction regimens in acute nonlymphocytic leukemia.
    Brennan DC; Lewis JP
    West J Med; 1980 Oct; 133(4):279-88. PubMed ID: 7347042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose cytosine arabinoside in the consolidation therapy of acute nonlymphocytic leukemia in remission.
    Takaku F; Urabe A; Mizoguchi H; Hoshino S; Toyama K; Tanaka K; Nomura T; Dan K; Fujioka S; Saito T
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):55-7. PubMed ID: 3589698
    [No Abstract]   [Full Text] [Related]  

  • 11. Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study.
    Farag SS; Ruppert AS; Mrózek K; Mayer RJ; Stone RM; Carroll AJ; Powell BL; Moore JO; Pettenati MJ; Koduru PR; Stamberg J; Baer MR; Block AW; Vardiman JW; Kolitz JE; Schiffer CA; Larson RA; Bloomfield CD
    J Clin Oncol; 2005 Jan; 23(3):482-93. PubMed ID: 15534356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Full dose versus attenuated dose daunorubicin, cytosine arabinoside, and 6-thioguanine in the treatment of acute nonlymphocytic leukemia in the elderly.
    Kahn SB; Begg CB; Mazza JJ; Bennett JM; Bonner H; Glick JH
    J Clin Oncol; 1984 Aug; 2(8):865-70. PubMed ID: 6379120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol.
    Berman E; Arlin ZA; Gaynor J; Miller W; Gee T; Kempin SJ; Mertelsmann R; Andreeff M; Reich L; Nahmias N
    Leukemia; 1989 Feb; 3(2):115-21. PubMed ID: 2911205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy for adult acute nonlymphocytic leukemia with daunorubicin and cytosine arabinoside.
    Cassileth PA; Katz ME
    Cancer Treat Rep; 1977 Nov; 61(8):1441-5. PubMed ID: 922749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and results.
    Wolff SN; Herzig RH; Fay JW; Phillips GL; Lazarus HM; Flexner JM; Stein RS; Greer JP; Cooper B; Herzig GP
    J Clin Oncol; 1989 Sep; 7(9):1260-7. PubMed ID: 2769327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential high-dose ara-C and asparaginase in the therapy of previously treated and untreated patients with acute leukemia.
    Capizzi RL; Powell BL; Cooper MR; Stuart JJ; Muss HB; Richards F; Jackson DV; White DR; Spurr CL; Zekan PJ
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):105-13. PubMed ID: 3892697
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination chemotherapy with daunorubicin, cytosine arabinoside and prednisolone (DAP) in acute nonlymphocytic leukemia.
    Kaku K; Nakashima K; Shinohara K; Hiroshige Y; Ishida Y; Fujii S; Yaga K; Matsumoto N; Miwa S
    Nihon Ketsueki Gakkai Zasshi; 1981 Jul; 44(4):881-6. PubMed ID: 7331708
    [No Abstract]   [Full Text] [Related]  

  • 18. Probable cures of adult acute leukemia using short term intensive investigational chemotherapy.
    Vaughan WP; Karp JE; Burke PJ
    Nebr Med J; 1984 Aug; 69(8):264-8. PubMed ID: 6483053
    [No Abstract]   [Full Text] [Related]  

  • 19. [The curative treatment of adult acute nonlymphocytic leukemia].
    Uzuka Y; Saito Y
    Rinsho Ketsueki; 1989 Aug; 30(8):1163-6. PubMed ID: 2601025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postremission chemotherapy for adults with acute myelogenous leukemia: improved survival with high-dose cytarabine and daunorubicin consolidation treatment.
    Champlin R; Gajewski J; Nimer S; Vollset S; Landaw E; Winston D; Schiller G; Ho W
    J Clin Oncol; 1990 Jul; 8(7):1199-206. PubMed ID: 1694236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.